The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...

The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

There is currently no screening programme for prostate cancer, the most common cancer in men. But there has been some ...

The UK National Screening Committee has advised against routine screening for prostate cancer with the prostate specific antigen (PSA) blood test, saying that the harms would outweigh the benefits.

The UK National Screening Committee (UK NSC) has rejected calls for population-wide prostate cancer screening using the PSA ...

Prostate cancer incidence is predicted to double to 2·9 million cases by 2040. Men diagnosed with clinically significant prostate cancer have many effective treatment options, but questions remain ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years later, here's his his journey since then.

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 ...